Progyny, Inc. (PGNY)
NASDAQ: PGNY · IEX Real-Time Price · USD
29.14
+0.54 (1.89%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Progyny Revenue

Progyny had revenue of $278.08M in the quarter ending March 31, 2024, with 7.62% growth. This brings the company's revenue in the last twelve months to $1.11B, up 26.94% year-over-year. In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth.

Revenue (ttm)
$1.11B
Revenue Growth
+26.94%
P/S Ratio
2.50
Revenue / Employee
$1,958,095
Employees
566
Market Cap
2.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B301.69M38.34%
Dec 31, 2022786.91M286.29M57.19%
Dec 31, 2021500.62M155.76M45.17%
Dec 31, 2020344.86M115.18M50.15%
Dec 31, 2019229.68M124.28M117.92%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
Envista Holdings 2.56B
Evolent Health 2.18B
iRhythm Technologies 513.17M
MorphoSys AG 264.75M
Kymera Therapeutics 79.41M
SpringWorks Therapeutics 26.45M
Geron 520.00K
Revenue Rankings